Controlled-Release Paxil Is Effective and Well Tolerated for Social Anxiety Disorder

MAY 01, 2004
Susan Farley

A multicenter, randomized, double-blind, flexible-dose study showed that 3 times as many patients with social anxiety disorder achieved remission while taking Paxil CR, compared with those taking placebo. The study, published in the Journal of Clinical Psychiatry, also showed that patients had a significantly reduced score on the Liebowitz Social Anxiety Scale, as well as on Fear or Anxiety and Avoidance subscales. Paxil CR is the first and only controlled-release selective serotonin reuptake inhibitor indicated for social anxiety disorder, the most common type of anxiety disorder. Paxil CR also is indicated for treating depression, panic disorder, and premenstrual dysphoric disorder.



SHARE THIS SHARE THIS
0
 

In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine

Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.